Nature Spinoff Prize
![](https://trincebio.com/wp-content/uploads/2024/07/PHOTO-2024-07-11-19-03-20-473x1024.jpg)
Trince, a spin-off from Ghent University, has won the prestigious Nature Spinoff Prize from the scientific journal Nature. This award, which is awarded globally, recognizes spin-offs that translate original, high-quality scientific research into products and services that address market problems and have a positive impact on society. In the final, Trince eventually beat two American and one British opponent.
The EOS is a well-known magazine in Belgium and The Netherlands for popular science. (Dutch only).
![](https://trincebio.com/wp-content/uploads/2024/07/Schermafbeelding-2024-07-03-om-13.10.47.png-1024x547.jpg)
Ziektes behandelen met fotoporatie: ‘Je wilt iets in de
cel brengen, maar die tegelijkertijd zo gezond mogelijk
achterlaten’
UGent spin-off nominated for prestigious Nature Spinoff Prize
![](https://trincebio.com/wp-content/uploads/2024/06/IMG_4405-1024x683.jpg)
Trince, an innovative spin-off from Ghent University, is one of four finalists for the global Spinoff Prize from the scientific journal Nature.
This prestigious award is given to spin-offs that translate original, high-quality scientific research into products and services that address market problems and have a positive impact on society. Trince has been nominated for its groundbreaking research into photoporation, a new and safer method of introducing DNA and other molecules into cells, such as in immunotherapy or gene therapy.
The word is out
![](https://trincebio.com/wp-content/uploads/2024/06/Schermafbeelding-2024-06-12-om-14.46.22-1024x428.jpg)
Very proud to announce that TrinceBio is longlisted for the Nature Spinoff Prize!We are working hard on our non-viral cell engineering platform and are happy to receive recognition for the potential and way forward of our technology.
European Innovation Council Awards
![](https://trincebio.com/wp-content/uploads/2023/12/Schermafbeelding-2023-12-13-om-15.49.35-1.png-1024x572.jpg)
European Innovation Council Awards €2.5 Million Grant to Trince, NecstGen, and IBSAL for Advancing Cell Therapy Manufacturing
The HealthTech Investor Summit
![](https://trincebio.com/wp-content/uploads/2023/12/Schermafbeelding-2023-12-13-om-15.49.35-1.png-1024x572.jpg)
Philip Mathuis pitched on the HealthTech Investor Summit !
Highly Cited Researcher
![](https://trincebio.com/wp-content/uploads/2023/10/ESGCT-Visual-for-Invitation-1024x512.jpg)
Our CSO Professor Kevin Braeckmans is again on this year’s Clarivate list of highly cited researchers. We are proud.
Advancing Cell Therapy: Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells
![](https://trincebio.com/wp-content/uploads/2023/10/ESGCT-Visual-for-Invitation-1024x512.jpg)
In the pursuit of refining adoptive T cell transfer, a critical facet of cell therapies, a recent study Ghent University delves into the application of Photothermal Electrospun Nanofibers (PEN) for intracellular delivery. This technique has proven efficient for activated T cells and now presents a promising avenue for unstimulated T cells.
Photoporation: a promising strategy for the generation of CAR-NK cells
![](https://trincebio.com/wp-content/uploads/2023/10/ESGCT-Visual-for-Invitation-1024x512.jpg)
Another milestone achieved by Charlotte Hinnekens from Ghent University who was able to generate CAR-NK cells by using photoporation.
Reach out if you wish to know more about the technology used. info@trincebio.com
Gentle Technologies for Cell Processing
![](https://trincebio.com/wp-content/uploads/2023/10/ESGCT-Visual-for-Invitation-1024x512.jpg)
We are excited to announce a collaboration by three innovative startups: LiveDrop, Aenitis Technologies, and Trince. The event, titled “Gentle Technologies for Cell Processing”,